Phase III study of gemcitabine (G) plus paclitaxel (T) versus T in patients with metastatic breast cancer (MBC) – Post-study chemotherapy (PSC) trend analysis
A. Llombart, S. Nag, G. Calderillo-Ruiz, J. Rolski, A. Pluzanska, L. Simms, K. Look, J. Gill, A. Melemed, J. O'ShaughnessyVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70884-x
File:
PDF, 58 KB
english, 2008